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Immune system defects are at the center of aging
and a range of diseases. Here, we show that pro-
longed fasting reduces circulating IGF-1 levels and
PKA activity in various cell populations, leading to
signal transduction changes in long-term hemato-
poietic stem cells (LT-HSCs) and niche cells that
promote stress resistance, self-renewal, and line-
age-balanced regeneration. Multiple cycles of fast-
ing abated the immunosuppression and mortality
caused by chemotherapy and reversed age-depen-
dent myeloid-bias in mice, in agreement with prelim-
inary data on the protection of lymphocytes from
chemotoxicity in fasting patients. The proregenera-
tive effects of fasting on stem cells were recapitu-
lated by deficiencies in either IGF-1 or PKA and
blunted by exogenous IGF-1. These findings link
the reduced levels of IGF-1 caused by fasting to
PKA signaling and establish their crucial role in regu-
lating hematopoietic stem cell protection, self-
renewal, and regeneration.
INTRODUCTION
Prolonged fasting (PF) lasting 48–120 hr reduces progrowth
signaling and activates pathways that enhance cellular resis-
tance to toxins in mice and humans (Fontana et al., 2010; Gue-
vara-Aguirre et al., 2011; Holzenberger et al., 2003; Lee and
Longo, 2011; Longo et al., 1997). The physiological changes
caused by PF are much more pronounced than those caused
by calorie restriction or fasting lasting 24 hours or less in part
because of the requirement to fully switch to a fat- and ketone810 Cell Stem Cell 14, 810–823, June 5, 2014 ª2014 Elsevier Inc.bodies-based catabolism after glycogen reserves are depleted
during PF (Longo and Mattson, 2014). Studies in mice indicate
that PF can protect them from chemotoxicity by reducing circu-
lating insulin-like growth factor-1 (IGF-1) (Lee et al., 2010; Raffa-
ghello et al., 2008). A preliminary case series study also indicates
thatPFhas thepotential to ameliorate several side effects caused
by chemotherapy in humans (Safdie et al., 2009). One of the side
effects, myelosuppression, is often dose limiting in chemo-
therapy treatment, in part because damage to adult stem/pro-
genitor cells impairs tissue repair and regeneration (Kofman
et al., 2012; Mackall et al., 1994; van Tilburg et al., 2011; Williams
et al., 2004). Despite the rising interest in nutrient-dependent
changes in stem cell populations, little is known about how acute
or periodic dietary interventions affect the hematopoietic system.
Hematopoietic stem and progenitor cells (HSPCs) residing in
the adult bone marrow (BM) are part of the LinSca-1+c-Kit+
(LSK) population of cells, which include the self-renewing
long-term and short-term hematopoietic stem cells (LSK-
CD48CD150+, LT-HSC, and LSK-CD48CD150, ST-HSC)
and the multipotent progenitors (LSKCD48+, multipotent pro-
genitor [MPP]) (Figure S1 available online) (Challen et al., 2009;
Rathinam et al., 2011). Together, these cells are responsible
for adult hematopoietic regeneration. In the heterogeneous he-
matopoietic stem cells (HSCs), several subtypes are identified as
lymphoid- (Ly-HSCs), balanced HSC (Bala-HSC), and myeloid-
HSCs (My-HSCs) according to their distinct mature blood cell
outputs (Figure S1) (Benz et al., 2012; Challen et al., 2010;
Muller-Sieburg et al., 2004). In both mice and humans, these
HSC subtypes modulate hematopoietic lineage potential and
play an important role in lineage-homeostasis during aging
(Beerman et al., 2010; Challen et al., 2010; Cho et al., 2008;
Pang et al., 2011). Here, we studied the role of multiple PF cycles
on chemotherapy-induced and age-dependent immunosup-
pression and investigated how PF affects HSC self-renewal,
the Ly-, My-, and Bala-HSC subtypes aswell as their hematopoi-
etic reconstitution outcomes.
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Cycles of Prolonged Fasting Reduce Damage in Bone
Marrow Stem and Progenitor Cells and Protect Mice
against Chemotoxicity
Chemotherapy drugs cause immunosuppression by inducing
DNA damage and cell death in both peripheral blood (PB) and
bone marrow (BM), which often results in the long-term impair-
ment of hematopoiesis (Bedford et al., 1984; Yahata et al.,
2011). To test whether PFmay protect the hematopoietic system
against immunosuppressive toxicity, mice were fasted or fed an
ad libitum diet (AL) and then challenged with cyclophosphamide
(CP) for multiple cycles (Figure 1A) (Adams et al., 2007). In agree-
ment with our previous results with etoposide and doxorubicin,
weobservedamajorprotectiveeffect of cyclesof 48hrPFagainst
CP-induced mortality (Figures 1B and S1A) (Raffaghello et al.,
2008). The PF cycles also led to a decrease in the DNA damage
caused by CP in leukocytes and BM cells (Figures 1C and S1B).
To determine whether PF can protect from chemotherapy-
induced toxicity, we collected BM cells at the end of six cycles
of CP or PF + CP treatments and measured apoptosis. Given
that the HSPCs represent a minor fraction of the total BM, we
further examined apoptosis in the subpopulations of these cells
(i.e., LT-HSCs,ST-HSCs, andMPPs)byperformingTUNELassay.
The results indicate thatwithout affectingBMcellularity, PFdimin-
ished CP-induced apoptosis in HSPCs (p < 0.05, t test), particu-
larly in ST-HSCs and MPPs (Figures 1D, S1C, and S1D). The
PF-induced protection against CP-induced apoptosis was also
confirmed by Annexin V binding assay for HSPCs (Figure S1E).
Prolonged Fasting Cycles Promote Lineage-Balanced
Hematopoietic Regeneration
To assess whether the protection of HSPCs improved the
hematopoietic recovery,wecompared thehematological profiles
of CP and PF + CP mice at baseline (before CP treatments, after
PF), at nadir (2–4days afterCP) andduring the recoveryphase (8–
10 days after CP) for each cycle of chemotherapy. Multicycle CP
treatments resulted in a major decline in white blood cell (WBC)
counts (Figure 1E). In the control group,WBCsuppression, espe-
cially thenumberof lymphocytes, persisted formore than70days
(six cycles) (Figure 1E). PF reducedWBCcounts independently of
chemotherapy and did not prevent the CP-induced decrease in
the number of WBCs (Figure 1E, time 0). However, the beneficial
effect of PF was evident starting on cycle 4 (day 39) followed by
the return of lymphocytes to normal levels after the fifth cycle
(day 56) (Figure 1E). At the end of six cycles of treatment, mice
in the PF group also showed normal or close to normal levels of
lymphoid cells and normal ratios of lymphoid and myeloid cells
(L/M) (Figure 1E, right panel). This recovery was observed at
similar time points in three independent experiments (n = 20).
To begin to determine whether PF cycles can potentially pro-
mote a similar effect in humans, we also analyzed the hemato-
logical profiles of cancer patients from a phase I clinical trial for
the feasibility and safety of a 24–72 hr PF period in combination
with chemotherapy. Although three different platinum-based
drug combinations were used (Table S1), the results from a
phase I clinical trial indicate that 72 but not 24 hr of PF in combi-
nation with chemotherapy were associated with normal lympho-
cyte counts and maintenance of a normal lineage balance inWBCs (Figure 1F). These encouraging preliminary results will
need to be expanded and confirmed in the ongoing phase II ran-
domized phase of the clinical trial.
In agreement with the effect of PF on the recovery in WBC
numbers and improvement in lymphoid/myeloid ratio, results
of fluorescence-activated cell sorting (FACS) analyses for stem
cell populations indicated an improved preservation of LT-
HSCs and ST-HSCs and the enhanced resistance to the myeloid
bias in the PF group after six cycles of CP treatment in mice (Fig-
ures 1G and 1H).
To assess whether the increased HSCs in BM from PF + CP
mice can enhance hematopoietic regeneration, we collected
BM cells from the CP- or PF + CP-treated mice and transplanted
the same number of cells into the immunocompromised (irradi-
ated) recipient mice. Results of this competitive repopulation
assay indicate that, compared to the control group fed ad libi-
tum, the BM cells from mice exposed to six cycles of CP treat-
ment preceded by PF have higher regeneration capacity leading
to efficient blood reconstitution with normal lymphoid/myeloid
ratio (L/M), as evident from the improved engraftment in the
blood and BM (Figures 1I, S1G, and S1H).
Prolonged Fasting Cycles Regulate Stem Cells
Independently of Chemotherapy and Help Reverse
Immunosenescence
Wetestedwhether thecyclesofPFalonecouldalsostimulateHSC
self-renewal. Results using bromodeoxyuridine (BrdU) incorpora-
tion assays indicated an approximately 6-fold increase of newly
generated (BrdU+) HSPCs (i.e., LT-HSC, ST-HSC, and MPP) in
PF mice, which represents 93.7% of the total increase in HSPCs
after PF cycles (Figure 2A). We found that the increase in LSK
cell number is due mainly to an increase in LT-HSCs and ST-
HSCs (Figure 2B). By contrast, the number of total BM cells and
that of progenitors (i.e., MPP, multipotent progenitors; CLP, com-
mon lymphoid progenitors; CMP, common myeloid progenitor)
was not increased by PF, and, in fact, the number of CMP was
slightly decreased during PF (Figures 2C and S2A).
Results fromcell-cycle analyses indicate thatPFalone induced
a major increase of S/G2/M phase LT-HSCs, ST-HSCs, and
MPPs (Figure 2D). The significant induction in cell-cycle entry
could explain at least part of the PF-induced increase in HSCs.
In addition to theKi67/Hoechst 33342 staining for cell-cycle anal-
ysis, the PF-induced self-renewal proliferation was confirmed by
analysis using Pyronin Y/Hoechst 33342 staining (Figure S2B).
On the other hand, results from the TUNEL assay indicate that
apoptosis was barely detectable in any subpopulation of HSPCs
from either AL-fed or PF mice when no chemotherapy treatment
was applied. Apoptosis analysis using Annexin V and 7AAD indi-
cate similar results (Figure S2C). Although PF alone reduces the
apoptosis rate in ST-HSCs significantly, the small reduction
(from 1.57% to 0.72%) in apoptosis/cellular death could only
contribute to a very small portion of the PF-induced increase in
HSCs and MPP (Figure 2E). However, because studies of HSCs
have shown that induction of proliferation may sometimes be
accompanied by an increase of apoptosis (Nakada et al., 2010;
Tothova et al., 2007), it is important to note that this was not
observed in PF-induced self-renewal proliferation.
Besides the increase in the number of HSCs and MPP,
we also observed a PF-dependent alteration of lymphoid-,Cell Stem Cell 14, 810–823, June 5, 2014 ª2014 Elsevier Inc. 811
Figure 1. Prolonged Fasting Cycles Protect the Hematopoietic System and Reverse Chemotherapy-Induced Hematopoietic Suppression
(A) Diagrammatic representation of the experimental procedure to analyze the effects of prolonged fasting (PF, 48 hr) during six cycles of cyclophosphamide
chemotherapy (CP, 200 mg/kg, i.p.).
(legend continued on next page)
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S2E).Whereasmost HSCs from youngmice are balanced in lym-
phopoiesis and myelopoiesis, the majority of HSCs from elderly
mice are myeloid biased (Beerman et al., 2010; Challen et al.,
2010; Cho et al., 2008; Dykstra et al., 2007; Morita et al., 2010;
Muller-Sieburg et al., 2004; Pang et al., 2011). We therefore
investigated if PF cycles can correct this bias in aged mice.
Results from 18-month-old mice indicate that eight cycles of
PF could reverse the age-dependent myeloid bias in HSC
subtypes and reverse the effect of aging on WBC number in
whole blood (Figures 2F and 2G), similar to the changes
observed in mice and possibly patients undergoing PF in com-
bination with chemotherapy (Figures 1E, 1F, and 1H). Taken
together, these results suggest that PF cycles can also stimulate
the HSCs in a chemotherapy-independent manner, which leads
to a lineage-balanced hematopoietic regeneration.
Mimicking the Effects of Prolonged Fasting by
Deficiency in GHR/IGF-1 Signaling Promotes
Hematopoietic Recovery
Wepreviouslyshowed thatPF reducescirculating IGF-1 levelsand
that IGF-I deficiency is sufficient to protect mice against chemo-
therapy toxicity (Lee et al., 2010). To determine whether the
improved hematopoietic regeneration caused by PF in mice can
be replicated by IGF-1 deficiency, we studied the hematopoietic
system in growth hormone receptor knockout (GHRKO) mice,
which have very low circulating and BM IGF-1 levels (Al-Regaiey
et al., 2005) (Figures 3A and S3A; Table S2). We found that CP-
induced DNA damage measured by the comet assay in PB and
BM cells of GHRKO mice was significantly reduced compared to
that in cells from wild-type littermates (Figure 3B). Similar to what
was observed in mice undergoing pre-chemo PF cycles, ST-
HSCs of the GHRKO mice were protected from CP-induced
apoptosis (Figure 3C). Also, the number of HSCs (i.e., LT-HSCs
and ST-HSCs) preserved in the BM of GHRKO mice was higher
than that in the wild-type littermates (Figure 3D). An improvement
in hematopoietic recovery analogous to that caused by PF was
also observed in GHRKO mice (Figure 3E).
We found that IGF-1 deficiency also caused the protective
effects and the regenerative effects independently of chemotox-
icity. Unlike PF mice, GHRKO mice did not have higher levels of(B) Survival curve with vertical dashed lines indicating the prechemo fasting peri
(C) DNA damage measurement (olive tail moment) in bone marrow (BM) cells (da
(D) Apoptosis measurement (TUNEL assay) in HSCs and MPP (day 81, sixth rec
(E) Hematological profile of mice. Total white blood cell (WBC), lymphocyte co
(200 mg/kg, i.p.). Each point represents the mean ± SEM; horizontal dashed lines
CP versus PF + CP during the recovery phase, n = 12 (six male and six female); L/M
number of myeloid cells (i.e., granulocytes and monocytes). See also Figures S1
(F) Hematological profile of human subjects. Lymphocyte counts and lymphoid/m
based doublet chemotherapy in combination with either 24 or 72 hr (48 before an
chemo) and eighth day after each chemotherapy cycle; each point represents t
rentheses.
(G) FACS analysis of hematopoietic stem and progenitor cells (day 84, end of six
(H) Proportion of the lymphoid-biased (Ly-HSC), balanced (Bala-HSC), and of th
lower side population of LSK (lower-SPLSK) for My-HSC, middle-SPLSK for Bala-HS
SP population in the upper panels. *p < 0.05, one-way ANOVA comparing to AL
(I) BM cells collected frommice treated with either CP or PF +CPwere transplante
BM was determined 16 weeks after primary BM transplantation. The ratio of lym
For (G) and (I), n = 6–10 per group, *p < 0.05, **p < 0.01, t test comparing the PF
treatment. Error bars represent SEM.total HSPCs (Figure S3B). However, similarly to what we
observed after PF cycles, the levels of HSCs (i.e., LT-HSCs
plus ST-HSCs) was significantly higher in GHRKO mice
compared to those in age- and sex-matched littermates, with
increased cell-cycle entry but no detectable differences in
apoptosis (Figures 3F, 3G, and S3C–S3E). Also, the age-depen-
dent myeloid bias was not observed in the GHRKO mice
(Figure 3H). These data suggest that the periodically reduced
IGF-1 signaling caused by PF cycles may play a crucial role in
the hematopoietic regeneration observed in mice.
Prolonged Fasting Promotes Hematopoietic
Regeneration in a IGF-1/PKA-Dependent Manner
To understand the molecular mechanism by which PF and GHR/
IGF-1 deficiency promote hematopoietic recovery/regeneration,
we reanalyzed two of our previously published microarray data
sets and looked for genes whose expression significantly
changed in response toPFwitha focusongenessimilarlyaffected
by exposure of epithelial cells to IGF-1-deficient serum (Guevara-
Aguirre et al., 2011; Kim and Volsky, 2005; Kirschner et al., 2009;
Lee et al., 2012). In starved mice, the expression of the PKA cata-
lytic subunit alpha (PKACa) was significantly reduced in all tissues
tested (Table S3). Similarly, IGF-1-deficient serum from growth
hormone receptor-deficient (GHRD) human subjects caused
changes in theexpressionofbothpositiveandnegative regulators
ofPKAconsistentwithan inhibitionof its kinase activity (TableS4).
As PKA phosphorylates the cAMP response element-binding
transcription factor (CREB) at Ser133, p-CREB is commonly
used as an indicator of intracellular PKA activity (Gonzalez and
Montminy, 1989). Using mouse embryonic fibroblasts devoid
of the endogenous IGF-1 receptor (R- cells) and those overex-
pressing the human IGF1R (R+ cell), we showed that CREB
phosphorylation is positively regulated by IGF-1/IGF-1R in a
PKA-dependent manner, confirming the link between IGF-1
and PKA/CREB signaling in mammalian cells (Figure 4A). IGF-1
receptor (IGF-1R) expression, which was higher in progenitor
cells compared to LT-HSCs (Venkatraman et al., 2013), was
not affected by PF (Figure S4A). Taken together, our in vivo re-
sults indicate that PF reduces PKA signaling in BM cells at
least in part through reduced IGF-1 levels, but without affecting
IGF-1R expression (Figure 4B).od; p < 0.01, log-rank (Mantel-Cox) test; n = 20 (ten male and ten female).
y 81, sixth recovery phase).
overy phase).
unts, and lymphoid/myeloid ratio (L/M) in mice treated with six cycles of CP
indicate the ranges of baseline values; *p < 0.05, two-way ANOVA, comparing
ratio of peripheral blood (PB) is defined as number of lymphocytes divided by
F and S1G.
yeloid ratio (L/M) in patients undergoing two cycles (C1 and C2) of platinum-
d 24 hr after chemo) prolonged fasting; D1 and D8 indicate the first day (before
he mean ± SEM; **p < 0.01, two-way ANOVA; sample size is indicated in pa-
th cycle); horizontal dashed lines indicate the baseline value.
e myeloid-biased (My-HSC) hematopoietic stem cells. The markers used are
C, and upper-SPLSK for Ly-HSC. The lower panels show amagnification of the
.
d into the recipient mice. The chimerism of donor-derived cells in PB and that in
phocytes to myeloid cells (L/M) in the reconstituted blood was also measured.
with the nonfasted control group both in combination with cyclophosphamide
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Figure 2. Prolonged Fasting Cycles Promote Chemotherapy-Independent Hematopoietic Regeneration
Mice in the control group were fed ad libitum and those in the PF group were fasted for one or two cycles as indicated. n = 4–12 female mice per group. Error bars
represent SEM.
(A) BrdU incorporation assay for LSK cells. Mice undergoing 24 + 48 hr prolonged fasting were injected (i.p.) with BrdU (0.1 mg/g, twice a day, for 2 days, starting
after 24 hr of fasting.
(B) Number of long-term hematopoietic stem cells (LT-HSC), short-term hematopoietic stem cells (ST-HSC), and multipotent progenitors (MPP).
(C) Number of common lymphoid progenitors (CLP) and myeloid progenitors (MP)
(legend continued on next page)
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effects on HSCs, we tested whether exogenous IGF-1 can blunt
the effect of PF on HSC number and PKA activity. Fasted mice
were injected with IGF-1 (200 mg/kg) to reverse the reduction of
IGF-1 during PF. Results indicate that IGF-1 administration
significantly blunted PF-induced reduction of PKA/pCREB in
the LSKpopulation, particularly in HSCs (Figure 4C). It also blunt-
ed the PF-induced increase in HSCs but not in MPPs (Figure 4D;
Table S4). We further investigated whether the induction in HSCs
can lead to enhanced engraftment andwhether this effect is IGF-
1/PKA dependent. Results of competitive repopulation assays
indicate the PF improved hematopoietic reconstitution in PB
and in BM. This effect was blocked by exogenous IGF-1 (Figures
4E, 4F, S4B, and S4C). Results of secondary transplantation
further confirmed the effects in long-term repopulation capacity
(Figures 4G and 4H). Overall, these results strongly support a role
for lower IGF-1 and the consequent reduced activity of PKA in
PF-dependent stimulation of HSC self-renewal and the improve-
ment in both short- and long-term hematopoietic repopulation
capacities (Figures 4E–4H).
Because IGF-1R signaling and IGF-1 expression were both
reduced in the BM stromal niche cells (LinCD45) from fasted
mice (Figure 5A), we investigated whether the stromal niche
could play a role in promoting PF-induced HSC self-renewal by
reducing IGF-1 levels in the microenvironment (as previously
shown in Figure 3A). To test this, LT-HSCs were purified (CD45+
LSK CD150+CD48) from mice on either PF or the control diet
and then cross-exposed to the stromal niche cells (CD45Lin
fraction) from mice on either PF or the ad lib diet using coculture
systems (Figure 5B). Notably, LT-HSCs are unable to survive in
the absence of niche cells, so the isolated LT-HSCs were not
studied alone. Results indicate that the effect of PF on LT-HSC
is sufficient to promote the self-renewal of LT-HSC and its
capacity to generate ST-HSC and non-LSK progenitors (Lin-
non-LSK) (Figure 5C, comparing A to B, C to D). Also, the PF-
treated niche cells could increase the generation of ST-HSCs
from ad lib diet LT-HSCs (comparing A to C) and increases
further the ST-HSC number generated by PF-treated LT-HSCs
(comparing B to D). These results confirm the role of LT-HSCs
in mediating PF-dependent hematopoietic regeneration but
also indicate that niche cells exposed to PF can contribute to
the ST-HSC component of this regeneration in vitro.
Reduction of IGF-1 or PKA Signaling Promotes HSC
Self-Renewal
PKA has conserved proaging roles in yeast and mammals
(Fabrizio et al., 2001; Rinaldi et al., 2010). In yeast, integration
of an extra copy of the regulatory and inhibitory subunit of PKA,
BCY1 (BCY1oe) enhanced, whereasmutations inBCY1 that acti-
vate PKA decreased, cellular resistance to H2O2-induced oxida-
tive stress (Figure 6A) in agreement with our previous results with(D) Cell-cycle analysis for BM cells using Ki67 and Hoechst 33342.
(E) Apoptosis analysis for BM cells using TUNEL assay.
For (A)–(E), *p < 0.05, **p < 0.01, ***p < 0.005, t test comparing the AL-fed contro
(F) Proportion of the lymphoid-biased (Ly-HSC), balanced (Bala-HSC), and the m
side population of LSK (lower-SPLSK) for My-HSC, middle-SPLSK for Bala-HSC, a
(G) Number of lymphocytes and myeloid cells in young (6 months, 48 hr fasting)
For (F) and (G), *p < 0.05, **p < 0.01, and ***p < 0.005, one-way ANOVA.RAS2- and adenylate cyclase-deficient mutants (Fabrizio et al.,
2003; Fabrizio et al., 2001). In mammalian cells, it was confirmed
by us and others that disruption of PKA signaling protects against
stress (Figures S5A–S5C) (Yan et al., 2007).
The role of PKA in hematopoietic regeneration, however, is
poorly understood. It is known that PKA negatively regulates
Foxo1 and positively regulates CREB and G9a (Chen et al.,
2008; Gonzalez andMontminy, 1989; Lee et al., 2011; Yamamizu
et al., 2012a). FoxOs maintain hematopoietic stress-resistance,
self-renewal and lineage homeostasis (Tothova et al., 2007),
whereas CREB and G9a promote hematopoietic lineage com-
mitment and differentiation (Chen et al., 2012; Yamamizu et al.,
2012b). We found that in PF mice, the reduction of IGF-1/pAkt
and PKA/pCREB signaling was associated with an induction of
Foxo1 expression and a reduction of G9a (Figures 6B and
S5E), but it did not affect the expressions of Foxo3a and
Foxo4 (Figures S5F–S5H). Also, the results indicated that the
numbers of ST-HSC and MPP were significantly increased after
treatment with PKA small interfering RNA (siRNA) as well as after
treatment with IGF-1 siRNA (Figures 6C and S5D; Table S5), in
agreement with the finding that inhibition of G9a increases prim-
itive HSCs (Chen et al., 2012).
Given that inhibition of mTOR, another key effector of nutrient
signaling, is known to enhance HSC self-renewal and mainte-
nance autonomously and nonautonomously, we examined the
crosstalk between mTOR and PKA in HSCs and MPPs (Chen
et al., 2009; Huang et al., 2012). Ex vivo rapamycin (an mTOR
inhibitor) treatment alone did not cause an induction in the
number of HSCs as expected based upon previous studies
with in vivo treatments (Figure 6C) (Nakada et al., 2010; Yilmaz
et al., 2012). This could be due to the need for a longer period
of mTOR inhibition to achieve HSC induction (Nakada et al.,
2010). In fact, when cotreated with PKA siRNA, rapamycin
caused an additional induction in ST-HSC and MPP, compared
to that caused by PKA knockdown alone suggesting that
diminished PKA signaling promotes the induction of HSCs,
which can be further potentiated by mTOR inhibition in certain
stem and progenitor cell subpopulations (Figure 6C). Notably,
the double inhibition of PKA and mTOR resulted in the syner-
gistic induction in ST-HSC and MPP but blunted the induction
in LT-HSC caused by PKA knockdown alone, which is similar to
what was caused by IGF-R knockdown (Figure 6C), and in
agreement with the potential role for IGF-1 in the regulation
of both PKA and mTOR in HSCs (Fontana et al., 2010; Longo
and Fabrizio, 2002).
The BM cells treated with IGF-1R siRNA or PKA siRNA ex vivo
(exBM) were further transplanted into the irradiated recipient
mice to assess their hematopoietic reconstitution capacity. In
agreement with the effects observed in PF mice, the PKA or
IGF-1R-deficient BM cells caused a significant improvement in
engraftment in PB and in BM compared to untreated BM cellsls.
yeloid-biased (My-HSC) hematopoietic stem cells. The markers used are lower
nd upper-SPLSK for Ly-HSC.
and old (18 months, eight cycles of fasting) mice.
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confirmed by secondary transplantation (Figure S5I).
DISCUSSION
When considering changes in gene expression and metabolism,
as well as the levels of various hormones, PF promotes co-
ordinated effects that would be difficult to achieve with any
pharmacological or other dietary intervention. In yeast, the key
changes responsible for the protective effects of starvation are
the downregulation of the glucose-sensing Ras/adenylate
cyclase/PKA and of the amino acid-sensing Tor/Sch9 (S6K)
pathways (Figure 7A) (Fontana et al., 2010). When mutations in
both pathways are combined, cells are extremely resistant to
a wide variety of toxins and can live up to 5-fold longer than
normal (Fabrizio et al., 2001; Kaeberlein et al., 2005; Kenyon,
2001; Longo and Finch, 2003; Wei et al., 2009). In mammals,
mutations that cause deficiency in the GHR-IGF-1 axis promote
a range of phenotypes that overlap with those in the highly pro-
tected yeast with deficiencies in nutrient signaling pathways
including dwarfism, stress resistance, and longevity extension
(Figure 7A) (Lee and Longo, 2011). In fact, cells from GHR/
IGF-1-deficient mice are protected from multiple forms of stress
(Brown-Borg et al., 2009; Salmon et al., 2005) and the IGF-1-
deficient (LID) mice, with an over 70% reduction in circulating
IGF-1, are resistant to several chemotherapy drugs (Lee et al.,
2010). Here, we connect the GHR-IGF-1 and the PKA proaging
pathways by showing that PKA functions downstream of IGF-1
to sensitize BM cells in agreement with results in yeast and with
the previously established connection between IGF-1 and PKA
in mammalian neuronal cells (Subramaniam et al., 2005).
However, the studies of growth-deficient yeast andmice could
not have predicted the remarkable effect of PF cycles in promot-
ing stem cell-based regeneration of the hematopoietic system.
Calorie intake was previously shown to affect the balance of
stem cell self-renewal and differentiation, which is important
for somatic maintenance and long-term survival (Bondolfi
et al., 2004; Chen et al., 2003; Ertl et al., 2008; Jasper and Jones,
2010; Rafalski and Brunet, 2011; Rando and Chang, 2012). In
mice, chronic calorie restriction (CR) promotes the self-renewal
of intestinal stem cells, muscle stem cell engraftment and neural
regeneration, preserves the long-term regenerative capacity of
HSCs, and prevents the decline of HSC number during aging
in certain mouse strains (Lee et al., 2002; Bondolfi et al., 2004;
Cerletti et al., 2012; Chen et al., 2003; Ertl et al., 2008; RafalskiFigure 3. Deficiency in GHR-IGF-1 Signaling Promotes Hematopoietic
Measurements were performed in GHRKO and their age-matched littermates, w
mice per group. Error bars represent SEM.
(A) BM IGF-1 level in GHRKO mice and PF mice compared to wild-type mice fed
(B) DNA damage measurement (olive tail moment) in BM cells and mononuclear p
recovery phase).
(C) Apoptosis measurement (TUNEL assay) in hematopoietic stem and progenito
(D) Number of hematopoietic stem and progenitor cells (day 84, end of sixth cyc
(E) Total white blood cell (WBC) and lymphocyte counts in PB of GHRKOmice and
lines indicate CP treatments; horizontal dashed lines indicate baseline value; *p <
six cycles of CP treatments. PB L/M ratio is defined as the number of lymphocyt
(F) Number of long-term hematopoietic stem cells (LT-HSC) and short-term hem
(G) Cell-cycle analysis using Ki67 and Hoechst 33342.
(H) Number of lymphocytes and myeloid cells in young (aged 6 months) and old
For (B)–(D) and (F)–(H), *p < 0.05, **p < 0.01; t test comparing to the wild-type coand Brunet, 2011; Yilmaz et al., 2012). Reduction of mTOR
signaling has been implicated as one of the major molecular
mechanisms responsible for the effects of CR on enhanced
stem cell function (Huang et al., 2012; Rafalski and Brunet,
2011; Yilmaz et al., 2012). However, neither CR nor other dietary
intervention had previously been shown to promote a coordi-
nated effect leading to the regeneration and/or rejuvenation of
a major portion of a system or organ.
Because during PF mammalian organisms minimize energy
expenditure in part by rapidly reducing the size of a wide range
of tissues, organs, and cellular populations including blood cells,
the reversal of this effect during refeeding represents one of the
most potent strategies to regenerate the hematopoietic and
possibly other systems and organs in a coordinated manner.
Here, we show that PF causes a major reduction in WBC num-
ber, followed, during refeeding, by a coordinated process able
to regenerate this immune system deficiency by changes begin-
ning during the fasting period, which include a major increase in
LT-HSC and ST-HSC and redirection of the frequency of Ly-
HSC/Bala-HSC/My-HSC leading to a lineage-balanced mode.
In fact, we show that PF alone causes a 28% decrease WBC
number, which is fully reversed after refeeding (Figures 7B and
S2F). Even after WBCs are severely suppressed or damaged
as a consequence of chemotherapy or aging, cycles of PF are
able to restore the normal WBC number and lineage balance,
suggesting that the organism may be able to exploit its ability
to regenerate the hematopoietic system after periods of starva-
tion, independently of the cause of the deficiency (Figure 7B).
In agreement with our results, starvation protects germline
stem cells (GSCs) and extends reproductive longevity in
C. elegans through an adaptive energy shift toward the less
committed cells (Angelo and Van Gilst, 2009). In contrast,
short-term fasting (%24 hr) in Drosophila promotes the differen-
tiation of hematopoietic progenitors to mature blood cells (Shim
et al., 2012). It will be important to determine whether the
coordinated regenerative changes observed during PF and
refeeding may resemble at least in part the sophisticated pro-
gram responsible for the generation of the hematopoietic system
during development.
Recent studies revealed that HSCs rely heavily on the meta-
bolic programs that prevent aerobicmetabolism tomaintain their
quiescent state and self-renewal capacity (Ito et al., 2012; Ta-
kubo et al., 2013; Yu et al., 2013). In the case of PF, the energy
metabolism is switched progressively from a carbohydrate-
based to a fat- and ketone body-based catabolism, which couldRegeneration in Both Chemo-Treated and Untreated Mice
ith or without treatment with six cycles of CP (200 mg/kg, i.p.). n = 4–8 female
ad libitum (WT-AL), *p < 0.05, **p < 0.01, one-way ANOVA.
eripheral blood cells (PB) from GHRKO and their littermates (WT) (day 81, sixth
r cells (day 81, sixth recovery phase).
le); horizontal dashed lines indicate the chemo-free baseline value.
their littermates (WT); each point represents the mean ± SEM; vertical dashed
0.05, two-way ANOVA for recovery phases; lymphoid/myeloid ratio (L/M) after
es divided by the number of myeloid cells (i.e., granulocytes and monocytes).
atopoietic stem cells (ST-HSC).
(aged 18 months) mice.
ntrol.
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Figure 5. The Role of Stromal Niche in PF-Induced HSC Self-Renewal
(A) Levels of the indicated proteins in BM stromal niche cells (Lin-CD45).
(B) Diagrammatic representation of the coculture experiment.
(C) Number of CD45+ progenies generated by the purified LT-HSCs exposed to the indicated niche cells. Cells were grown in the contacting coculture system for
3 days and then analyzed by FACS. Error bars represent SEM.
*p < 0.05, **p < 0.01, and ***p < 0.005, t test for (A) and one-way ANOVA for (C).
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Fasting Inhibits IGF-1/PKA to Promote Regenerationcontribute to HSC self-renewal, in agreement with findings that
fatty acid oxidation promotes HSC asymmetric self-renewal
over the symmetric commitment (Ito et al., 2012).
PKA is known to promote lineage specification of HSC
through CREB and G9a (Chen et al., 2012; Yamamizu et al.,
2012b). As inhibition of G9a has been a key strategy to promote
reprogramming (Huangfu et al., 2008; Shi et al., 2008), the PF-
induced downregulation of G9a shown here may redirect cell
fate through a similar process causing the induction in HSCs,
analogously to that caused by G9a inhibition (Figure 5B)(ChenFigure 4. Prolonged Fasting Promotes IGF-1/PKA-Dependent Hemato
(A) PKA-dependent phosphorylation of CREB visualized by ICC inmouse embryon
human IGF1R (R+ cells). R+ cells were treated with IGF-1 and compared to cells
(B) Prolonged fasting (PF) reduces both circulating IGF-1 levels and PKA activity
(C and D) IGF-1 injection blunted the PF-induced (C) reduction of PKA/pCREB (D
(E–H) The chimerism of donor-derived cells in PB and that in the BM was determ
n = 4–8 female mice per group, *p < 0.05, **p < 0.01, and ***p < 0.005, one-wayet al., 2012). Recent studies also indicate that PKA can directly
phosphorylate and negatively regulate FoxO1 (Chen et al.,
2008; Lee et al., 2011), which has a profound role in stem cell
stress resistance, self-renewal and pluripotency maintenance
(Tothova et al., 2007; Zhang et al., 2011). Whereas PKA is impli-
cated in stem cell differentiation, our study suggests that cycles
of PF downregulate IGF-1 and PKA to promote stem cell self-
renewal.
A therapeutic challenge of hematopoietic regeneration is to
stimulate stem cell production for immediate tissue repair whilepoietic Regeneration
ic fibroblast (MEFs) devoid of endogenous IGF-1R (R cells) or overexpressing
transfected with PKACa siRNA.
in BM cells in mice.
) increase in hematopoietic stem cells.
ined 16 weeks after primary and secondary BM transplantation.
ANOVA. Error bars represent SEM.
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Figure 6. Reduction of IGF-1-PKA Signaling Promotes Hematopoietic Stem Cell Self-Renewal
(A) Yeast cells (DBY746 background) overexpressing BCY1 (BCY1oe), which reduces PKA activity, or cells carryingmutations that activate PKA activity (bcy1CA1
and bcy1CA2) were grown in SDC for 3 days and treated with H2O2 (50 or 100 mM) for 30 min at 30
C. Cells were serially diluted and plated onto YPD plates.
(B) PKA-regulated self-renewal pathways in PF mice. The levels of phosphorylation or expression of intracellular proteins in the indicated cellular populations
and expression of indicated genes in total BM cells. BM cells were collected frommice with or without 48 hr starvation (AL and PF). n = 4 female mice per group,
**p < 0.01, *p < 0.05, t test.
(C) Number of hematopoietic stem cells (per 53 105 total BM) and progenitor cells (LT-HSC, ST-HSC, and MPP) under the indicated treatments. *p < 0.05, **p <
0.01, and ***p < 0.005, one-way ANOVA. See also Figures S7F and S7G.
BM cells treated with PKA siRNA, IGF-1R siRNA or IGF-1 (versus nontreated cells) were transplanted into immunocompromised-recipient mice.
(D) The engraftment in PBwasmeasured at indicated time point after primary transplantation and the engraftment in BMwasmeasured at the end of the 16weeks
after primary transplantation. n = 4–8 female mice per group, *p < 0.05, **p < 0.01, and ***p < 0.005, one-way ANOVA.
Error bars represent SEM.
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Fasting Inhibits IGF-1/PKA to Promote Regenerationavoiding stem cell depletion under stress (Pang et al., 2011). Our
results indicate that cycles of an extreme dietary intervention
represent a powerful mean to modulate key regulators of cellular
protection and tissue regeneration but also provide a potential
therapy to reverse or alleviate the immunosuppression or immu-
nosenescence caused by chemotherapy treatment and aging,
respectively, and possibly by a variety of diseases affecting the
hematopoietic and immune systems and other systems and
organs. The clinical data shown here provide preliminary results
supporting the possibility that these effects can also be trans-
lated into effective clinical applications.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J mice (Jackson Laboratory) were used in this study. Mice are either
fasted for 48 hr or fed ad libitum before chemotherapy treatment. Cyclophos-820 Cell Stem Cell 14, 810–823, June 5, 2014 ª2014 Elsevier Inc.phamide (CP) was administered intraperitoneally (i.p.) at the dose of 200mg/kg
every 12–14 days (six cycles total). IGF-1 was injected (i.p.) at the dose of
100 mg/kg, twice a day. Six- to 8-week-old B6.SJL mice (Taconic) were
used as recipient mice in the competitive repopulation assay. Genotyping
for GHRKO mice was performed as shown in Figure S3A. All animal experi-
ments were done in accordance with the USC Institutional Animal Care and
Use Committee and NIH guidelines.
Comet Assay
DNA damage (including single-stranded DNA and double-stranded DNA
breaks) in freshly collected blood and bone marrow (BM) cells was assessed
by CometAssay (Trevigen) with a Nikon Eclipse TE300 fluorescent microscope
and analyzed with the Comet Score (TriTek, v.1.5). One hundred to two
hundred cells were scored per experimental sample.
Complete Blood Count
Peripheral blood (PB) was collected via tail bleeds into heparinized
microhematocrit capillary tubes (Fisher Scientific) was and analyzed using
BC-2800 Auto Hematology Analyzer (Mindray). CBC profiles from clinical
Figure 7. PF Reduces IGF-1/PKA to Pro-
mote Lineage-Balanced Hematopoietic
Regeneration
(A) A simplified model for a partially conserved
nutrient signaling PKA pathway in yeast and
mammalian cells. Arrows show activating actions,
and horizontal bars indicate inhibitory actions. GH,
growth hormone; AC, adenylate cyclase; PKA,
protein kinase A; CREB, cAMP response element-
binding protein; Foxo1, Forkhead box protein O1;
G9a, H3 Lys-9 methyltransferase.
(B) A simplified model for PF-induced effects on
WBC and HSCs. Fasting causes amajor reduction
in WBCs followed by their replenishment after re-
feeding, based on effects on HSCs self-renewal
resulting in increased progenitor and immune
cells. These effects of PF can result in reversal of
chemotherapy-based immunosuppression but
also in the rejuvenation of the immune cell profile in
old mice.
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by USC Institutional Review Boards (IRBs) (http://clinicaltrials.gov/show/
NCT00936364).
Competitive Repopulation Assay
BM collection and transplantation were performed as previously described
(Adams et al., 2007). Briefly, BM cells were collected from mice (C57B/6J)
treated with six cycle CP. BM cells (2.5 3 105) from CP-treated mice were
mixed with an equal number of those from a wild-type competitor mouse
(B6.SJL) and injected into recipient B6.SJL, lethally irradiated 24 hr previously
with 10 Gy of radiation. The relative contribution of engraftment from the
different cell sources was assessed by flow cytometry of the PB with
CD45.2 (C57B/6) and CD45.1 (B6.SJL) antigens.
FACS Analysis
FACS analyses for LT-HSCs (LSK-CD48CD150+), ST-HSCs (LSK-CD48
CD150), and MPPs (LSK CD48+CD150) in BM were performed as previ-
ously described (Figure S1) (Adams et al., 2007; Challen et al., 2010).
Freshly harvested BM cells were stained with lineage, stem, and progenitor
markers, followed by Annexin-V/7-AAD staining and TUNEL assay for
apoptosis analysis or stained with PY/Hoechst 33342 or Ki67/Hoechst
33342 for cell-cycle analysis. For competitive repopulation analysis, PBCell Stem Cell 14, 810–was collected from tail vein. Fifty to one hundred
microliters of blood was diluted 1:1 with PBS
and incubated with anti-CD45.1, anti-CD45.2 an-
tibodies, and anti-CD11b (BD Biosciences).
Analysis was performed with BD FACS diva on
LSR II.
BrdU Incorporation
For detecting cell genesis, mice were injected (i.p.)
with the filter sterilizedBrdU 2.0% solution (Sigma)
at 0.1 mg/g body weight in PBS, twice a day, for
2 days, starting after 24 hr of prolonged fasting
(PF mice). BM cells were collected and stained
with anti-BrdU combining with the plasma
membranemarker antibodies asmentioned above
and analyzed on BD FACS diva on an LSR II, ac-
cording to the manufacturer’s protocol (BD
Biosciences).
Oxidative Stress Assay for Yeast
Day 3 cells were diluted to anOD600 of 1 in K-phos-
phate buffer (pH 6) and treated with 50 or 100 mM
hydrogen peroxide for 30 min. Serial dilutions ofuntreated and treated cells were spotted onto YPD plates and incubated at
30C for 2–3 days.
Cell Culture and Treatments
Cell lines and primary cells used in this study were cultured at 37C and 5%
CO2. Mouse embryonic fibroblast with overexpressed human IGF1R (R
+ cells)
were derived from IGF1R knockout mice (obtained from Dr. Baserga) and
cultured in DMEM/F12 supplementedwith 10% fetal bovine serum (FBS). Cells
were seeded at 80% (R+ cells) or 50% (exBMor hAFSCs) confluence for IGF-1R
and PKACa siRNA transfection (100 nM, with 1% X-tremeGENE transfection
reagents, Roche) and/or rapamycin treatment (5 nM), and the inhibition effi-
ciencies of the target proteins are shown in Table S5. The IGF-1 induction
(10 nM, 15min) was performed at 24 hr after standard incubation. CREB phos-
phorylation was measured by immunocytochemistry (ICC) with the pCREB-
AF488 antibody (cell signaling, 1:200, overnight at 4C). Explanted BM cells,
isolated HSCs and BM stromal cells were incubated with alpha-MEM + 10%
FBS. Cell contents were analysis by FACS as described above.
Statistical Analysis
The significance of the differences in mouse survival curves was determined
by Log-rank (Mantel-Cox). Unless otherwise indicated in figure legends,
data are presented as means ± SEM. Student’s t tests for two groups and823, June 5, 2014 ª2014 Elsevier Inc. 821
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Fasting Inhibits IGF-1/PKA to Promote RegenerationANOVA for multiple groups were used to assess statistical significance
(*p < 0.05, **p < 0.01, ***p < 0.005).
SUPPLEMENTAL INFORMATION
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